Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood1996;88:3698.
2.
Vicente V., Gonzalez-Conejero R., Rivera J., et al. The prothrombin gene variant 20210A in venous and arterial thromboembolism . Haematologica1999;84:356.
3.
Bertina RMThe prothrombin 20210 G to A variation and thrombosis. Curr Opin Hematol1998;5:339.
4.
Rao AK, Kaplan R., Sheth S.Inherited thrombophilic states. Semin Thromb Hemost1998;24(suppl):3.
5.
Petitti DBAssociation are not effects. Am J Epidemiol1991;133: 101.
6.
Alatri A., Franchi F., Moia M.Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report. Thromb Haemost1998 ;80:1028.
7.
Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, et al. Prevalence of the prothrombin gene variant (nt20210)y in venous thrombosis and arterial disease. Thromb Haemost1997;78:1430.
8.
De Stefano V. , Chiusolo P., Paciaroni K., et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood1998;91:3562.
9.
Eikelboom JW , Ivey L., Ivey J., et al. Familial thrombophilia and the prothrombin 20210 A mutation: association which increased thrombin generation and unusual thrombosis. Blood Coagul Fibrinolysis1999 ;10:1.
10.
Girolami A. , Simioni P., Girolami B., et al. Low incidence of venous thrombosis in homozygous patients with nt20210 G to A prothrombin polymorphism. Clin Appl Thromb Haemost1999 ;5:205.
11.
Girolami A. , Simioni P., Manfrin A., et al. Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindreds. Clin Appl Thromb Hemost1999;5:48.
12.
Girolami A. , Simioni P., Tormene D., et al. Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis. Thromb Res1999;96:415.
13.
Gonzales Ordonez AJ, Medina Rodriguez JM, Fernandez Alvarez CR, et al. A patient homozygous for mutation 20210 A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin. Haematologica1998;83:1050.
14.
Howard TE, Marusa M., Channel C., et al. A patient homozygous for a mutation in the prothrombin gene 3'-untranslated region associated with massive thrombosis. Blood Coagul Fibrinolysis1997;8:316.
15.
Kapur RK, Mills LA, Spitzer SG, et al. A prothrombin gene mutation is significantly associated with venous thrombosis. Arterioscler Thromb Vasc Biol1997;17:2875.
16.
Kyrle PA, Mannhalter C., Beguin S., et al. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol1998;18:1287.
17.
Ridker PM, Hennekens CH, Miletich JPG20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation1999; 99:999.
18.
Scott CM, Hauley JP, Ludlam CA, et al. Homozygous for a factor II polymorphism associated with thrombosis during pregnancy. Proceedings of the XIV Congress International Society for Thrombosis and Haemostasis. Florence, Italy: International Society for Thrombosis and Hemostatis, 1997(suppl):770 [abstract HI-13].
19.
Zawadzki G. , Gavieraux V., Trillot N., et al. Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family. Thromb Haemost1998;80:1027.
20.
Halbmayer WM , Kalhis T., Haushofer A., et al. Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210 A/A prothrombin mutation and heterozygous 1691 G/A factor V Leiden mutation . Blood Coagul Fibrinolysis1999;10:297.
21.
Corral J., Zuazu-Jausoro I., Rivera J., et al. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family. Br J Haematol1999;105: 560.
22.
Wulf GM, Van Deerlin VM, Leonard Dgb, et al. Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene. Blood Coagul Fibrinolysis1999;10:107.
23.
Simioni P., Tormene D., Manfrin D., et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol1998;103:1045.
24.
Girolami A. , Scarano L., Saggiorato G., et al. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis1998;9:557.
25.
Zuazu-Jausoro I., Sanchez I., Fernandez MC, et al. Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 A allele of the prothrombin gene. Haematologica1998 ;83:1129.
26.
Casonato A. , Pontara E., Boscaro M., et al. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis1999;10:145.
27.
Patrassi GM , Dal Bo Zanon R., Boscaro M., et al. Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost1985;54:518.
28.
Girolami A. , Zanon E., Tormene D., et al. It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia or not. Blood Coagul Fibrinolysis1999;10:399.
29.
Simioni P., Prandoni P., Girolami A.Low rate of venous thromboembolism in asymptomatic relatives of probands with factor V Leiden mutation. Ann Intern Med1999 ;130:538 [letter].
30.
Simioni P., Prandoni P., Lensing Awa, et al. The risk of recurrent thromboembolism in patients with an Arg 506 Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med1997;336:399.
31.
Girolami A. , Simioni P., Scarano L., et al. Venous and arterial thrombophilia . Haematologica1997 ;82:96.
32.
Girolami A. , Simioni P., Scarano L., et al. Prothrombin and the thrombin 20210 G to A polymorphism: their relationship with hypercoagulability and thrombosis . Blood Rev (in press).
33.
Girolami A. , Scarano L., Girolami B., et al. Emphasis on congenital conditions predisposing to thrombosis should not make us disregard the importance of acquired factors. Blood Coagul Fibrinolysis1998;9:659.